Related Experiment Video
Updated: Aug 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease
Ming-Cheng Wang1, Wei-Chuan Tsai, Ju-Yi Chen
1Department of Internal Medicine, Division of Nephrology, National Cheng Kung University Medical Center, Tainan, Taiwan, ROC.
Insights
Arterial stiffness, measured by pulse wave velocity (PWV), increases with chronic kidney disease (CKD) progression. Lower estimated glomerular filtration rate (GFR) and higher systolic blood pressure are key factors in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) exhibit high rates of cardiovascular disease (CVD).
- Premature atherosclerosis and vascular calcification are significant contributors to CVD in CKD patients.
- Arterial stiffness is a key indicator of cardiovascular risk.
Purpose of the Study:
- To assess arterial stiffness severity in 102 CKD patients using pulse wave velocity (PWV).
- To identify risk factors associated with increased arterial stiffness in CKD.
Main Methods:
- Pulse wave velocity (PWV) was measured by calculating flow wave travel distance divided by time delay.
- Correlations were analyzed between PWV and cardiovascular risk factors, estimated glomerular filtration rate (GFR), blood pressure (BP), and pulse pressure (PP).
Main Results:
- PWV was similar in early CKD stages (1-2) and controls but increased significantly with advancing CKD stage.
- Univariate analysis revealed correlations between PWV and age, prior CVD, diabetes, hypertension, GFR, systolic BP, and PP.
- Multivariate analysis identified decreased GFR and increased systolic BP as independent predictors of increased PWV in CKD patients.
Conclusions:
- This study demonstrates a progressive increase in PWV with CKD stages 1-5.
- Reduced estimated GFR and elevated systolic BP are major determinants of arterial stiffness in CKD.
- These findings highlight the importance of managing GFR and BP to mitigate arterial stiffness in CKD patients.
Background:
Patients with end-stage renal disease on maintenance dialysis therapy have a high prevalence of cardiovascular risk factors and cardiovascular disease (CVD). A similar finding is noted in patients with chronic kidney disease (CKD). The important contributors are premature and accelerated atherosclerosis and vascular calcification. We assessed the severity of arterial stiffness in 102 patients with CKD by using pulse wave velocity (PWV) and sought to identify associated risk factors.
Methods:
PWV was measured by calculating the distance traveled by the flow wave and divided by the time delay. Correlations between PWV and traditional cardiovascular risk factors, estimated glomerular filtration rate (GFR) per 1.73 m2 , blood pressure (BP), and pulse pressure (PP) were analyzed.
Results:
PWV values in patients with CKD stages 1 to 2 and the age-matched control group were similar. There was a significant trend for a stepwise increase in PWV corresponding to advance in CKD stage (P < 0.0001). Univariate linear regression analysis showed that age, prior CVD, diabetes, hypertension, any high risk, estimated GFR per 1.73 m2 , systolic BP, and PP correlated with PWV. In the multivariate model, decreased estimated GFR per 1.73 m2 and increased systolic BP were independently associated with increased PWV in patients with CKD (model R 2 = 0.539; P < 0.0001).
Conclusion:
This is the first study to show a greater PWV in patients with more advanced CKD from stages 1 to 5. Estimated GFR per 1.73 m2 and systolic BP were the major clinical determinants of arterial stiffness in patients with CKD independent of conventional risk factors for CVD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy
Peripheral Artery Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
